|
US5585250A
(en)
|
1993-08-20 |
1996-12-17 |
The United States Of America As Represented By The Department Of Health & Human Services |
Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
EP1167379A3
(en)
|
1994-07-15 |
2004-09-08 |
University Of Iowa Research Foundation |
Immunomodulatory oligonucleotides
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
WO1998037919A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
EP1003531B1
(en)
|
1997-05-20 |
2007-08-22 |
Ottawa Health Research Institute |
Processes for preparing nucleic acid constructs
|
|
AU760549B2
(en)
|
1998-04-03 |
2003-05-15 |
University Of Iowa Research Foundation, The |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
|
WO2001075436A1
(en)
|
2000-04-03 |
2001-10-11 |
Board Of Trustees Of The Leland Stanford Junior University |
A method for protein structure alignment
|
|
ATE381575T1
(de)
|
2000-08-18 |
2008-01-15 |
Univ New York State Res Found |
Veränderte borrelia burgdorferi ospa
|
|
CN1659187A
(zh)
|
2002-05-10 |
2005-08-24 |
新世纪药品有限公司 |
融合铁蛋白在疫苗和其他方面的应用
|
|
US7774185B2
(en)
|
2004-09-14 |
2010-08-10 |
International Business Machines Corporation |
Protein structure alignment using cellular automata
|
|
EP1997830A1
(en)
|
2007-06-01 |
2008-12-03 |
AIMM Therapeutics B.V. |
RSV specific binding molecules and means for producing them
|
|
WO2009080719A1
(en)
|
2007-12-21 |
2009-07-02 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
US20110117131A1
(en)
|
2008-04-09 |
2011-05-19 |
Ning Huang |
Production of OspA for Lyme Disease Control
|
|
AU2011252844B2
(en)
|
2010-05-14 |
2014-07-03 |
Baxalta GmbH |
Chimeric OspA genes, proteins, and methods of use thereof
|
|
WO2012006180A1
(en)
|
2010-06-29 |
2012-01-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv immunogens
|
|
WO2012139069A2
(en)
|
2011-04-07 |
2012-10-11 |
Neotope Biosciences Limited |
Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
|
|
EP2515112B1
(en)
|
2011-04-22 |
2015-08-12 |
Sysmex Corporation |
Method for electrochemically detecting analyte
|
|
JP5795184B2
(ja)
*
|
2011-04-22 |
2015-10-14 |
国立大学法人 奈良先端科学技術大学院大学 |
被検物質の電気化学的検出方法
|
|
US9580475B2
(en)
|
2011-06-20 |
2017-02-28 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Computationally optimized broadly reactive antigens for H1N1 influenza
|
|
WO2013039792A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunogens based on an hiv-1 gp120 v1v2 epitope
|
|
EP4241785B1
(en)
|
2011-09-20 |
2026-01-28 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
EP2758038B1
(en)
|
2011-09-23 |
2018-05-30 |
The United States of America, as represented by The Secretary, Department of Health & Human Services |
Novel influenza hemagglutinin protein-based vaccines
|
|
CA2868330A1
(en)
|
2012-03-30 |
2013-10-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
|
|
BR112015001390B1
(pt)
|
2012-07-26 |
2024-04-30 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc |
Proteína de fusão, ácido nucleico isolado e uso de uma composição de vacina
|
|
EP2970398B1
(en)
*
|
2013-03-13 |
2024-05-08 |
The United States of America, as Represented by The Secretary, Department of Health and Human Services |
Prefusion rsv f proteins and their use
|
|
WO2015054639A1
(en)
|
2013-10-11 |
2015-04-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Epstein-barr virus vaccines
|
|
CZ2014320A3
(cs)
|
2014-05-09 |
2015-11-18 |
VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. |
Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy
|
|
US10363301B2
(en)
|
2014-05-27 |
2019-07-30 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Stabilized influenza hemagglutinin stem region trimers and uses thereof
|
|
US9703095B2
(en)
|
2015-01-05 |
2017-07-11 |
Edward Pakhchyan |
Light modulator for MEMS display
|
|
WO2016138160A1
(en)
*
|
2015-02-24 |
2016-09-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
|
|
EP3383426A1
(en)
*
|
2015-12-04 |
2018-10-10 |
Dana Farber Cancer Institute, Inc. |
Vaccination with mica/b alpha 3 domain for the treatment of cancer
|
|
WO2017172890A1
(en)
|
2016-03-29 |
2017-10-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Substitutions-modified prefusion rsv f proteins and their use
|
|
JP6974358B2
(ja)
*
|
2016-06-07 |
2021-12-01 |
ドイチェス クレブスフォルシュンクスツェントルム |
Ｈｐｖ ｌ２ペプチドの免疫原性の改善
|
|
BR112018076015A8
(pt)
|
2016-06-17 |
2022-06-28 |
Sanofi Pasteur |
Formulações imunogênicas compreendendo adjuvantes de polímero do ácido poliacrílico linear ou ramificado .
|
|
US10961283B2
(en)
|
2016-06-27 |
2021-03-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens
|
|
WO2018193063A2
(en)
|
2017-04-19 |
2018-10-25 |
Institute For Research In Biomedicine |
Novel malaria vaccines and antibodies binding to plasmodium sporozoites
|
|
MA50813A
(fr)
|
2017-11-21 |
2020-09-30 |
Modernatx Inc |
Vaccins contre le virus d'epstein-barr
|
|
KR20210018205A
(ko)
|
2018-04-03 |
2021-02-17 |
사노피 |
항원성 OspA 폴리펩타이드
|
|
JP2021519600A
(ja)
|
2018-04-03 |
2021-08-12 |
サノフイＳａｎｏｆｉ |
抗原性インフルエンザ−フェリチンポリペプチド
|
|
WO2019195314A2
(en)
|
2018-04-03 |
2019-10-10 |
Sanofi |
Antigenic epstein barr virus polypeptides
|
|
JP7614841B2
(ja)
|
2018-04-03 |
2025-01-16 |
サノフイ |
抗原性呼吸器合胞体ウイルスポリペプチド
|
|
EP3773698A1
(en)
*
|
2018-04-03 |
2021-02-17 |
Sanofi |
Ferritin proteins
|